Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
A legfontosabb adatok
- Hol
- Phoenix (Egyesült Államok)A helyszín megnézése
- Fázis
- 4. fázis
Helyszínek itt: Egyesült Államok
- Phoenix Children s HospitalPhoenix, Egyesült ÁllamokContact: Kevin Engelhardt, MDRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Phoenix Children's Hospital
- Azonosító
- NCT04040452
- A regiszteradat frissítve
- 2026. augusztus 12.
- Eredeti leírás
The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.A teljes eredeti leírásKevesebb
Continuous Infusion Versus Intermittent Ketorolac for Postoperative Pain Control in Pediatric Cardiac Surgery Patients
The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.
Bevonási feltételek: All patients aged 3 months to 4 years 11months admitted post operatively to the CVICU during the time period in which the study will be ongoing; Initiation of study medication within the first 12-24 hours post-operatively; The cardiovascular attending of record after review of the intraoperative course and post-operative laboratories determines the patient will receive Ketorolac for pain control.
Kizáró feltételek: Requiring mechanical circulatory support (ECMO) or continuous renal replacement therapy (CRRT) within the first 48 hours post-operatively; History of allergy or sensitivity reaction to ketorolac or any NSAID medications; Orthotopic heart transplantation; Clinically significant bleeding; Patients with known pre-operative medical renal disease, renal transplantation history, congenital or acquired renal abnormality or deformity; Patients that have acute kidney injury, as defined by the letter "I" in the pRIFLE criteria.